Lawrence Person's BattleSwarm Blog 9/9/2021
I had no intention on doing another post about using ivermectin in treating Flu Manchu (and Rolling Stone‘s shabby Oklahoma hit piece), but too many links of interest on the subject have popped up to ignore.
Again, I’m not a doctor, and can’t pretend to knowledgeably evaluate the competing claims and evidence of using ivermectin to relieve coronavirus symptoms. But a whole lot of The Usual Suspects in the Democratic Media Complex who have been wrong about almost everything when it comes to Mao Tze Lung seem suspiciously anxious to attack the possibility it’s efficacious. Such claims should be evaluated not for whether they help or hinder Democratic Party policy goals, but for results shown in well-constructed clinical trials. (And not the “Hey, we gave Ivermectin to coronavirus patients without zinc, vitamin D or antibiotics and they didn’t get any better” variety.)
So: Some links.
First up, here’s Joe Rogan discussing his own coronavirus treatment including Ivermectin, monoclonal antibodies, Z-pack, Prednisone, a NAD drip and a vitamin drip:
https://www.youtube.com/watch?v=3O_7O9_nV10The there’s
this piece pointed out by commenter Alec Rawls, which cites much lower coronavirus morbidity among Africans who regularly took Ivermectin for parasite control than among those who didn’t:
In the graphic above, the blue area shows the countries of Africa that distribute ivermectin once or twice a year for the control of parasites. The brown area is the countries that don’t. The brown line is the daily deaths from Covid per one hundred thousand people in those countries. The blue line is the same for the blue area — which is enjoying a far, far lower Covid death rate. A lot of the poor and backward countries of South America, Africa and Asia have now approved ivermectin for Covid.
Here’s a
balanced assessment of using Ivermectin to treat coronavirus:
It’s worth taking a bit of time first to understand the basis behind the excitement for ivermectin as a possible agent against Covid-19, as well as the reservations expressed by the medical establishment. Ivermectin, much more than a “horse dewormer,” is a genuinely useful anti-parasitic medication, used widely in our own species primarily for tropical diseases like onchocerciasis and lymphatic filariasis. While never tested in human subjects for possible antiviral properties prior to the arrival of SARS-CoV-2, it had been studied in the laboratory setting for theoretical properties against multiple viral pathogens. The potential for anti-inflammatory properties – the sort that, like fellow old generic, dexamethasone, could prove useful against Covid-19’s infamous cytokine storm – was also known. Topically applied, it has been shown to be anti-inflammatory, and is prescribed for the autoimmune skin condition, rosacea; and systemically, there exists some in vivo evidence (albeit in mice).
What are the chances that an antiparasitic with mere hints of anti-viral and anti-inflammatory properties would amount to the most effective medication on the face of the planet against SARS-CoV-2 on both counts? Slim, indeed. Much of the skepticism that I, and most of the medical establishment, felt towards ivermectin can be explained through that lens: the prior probability of these rather remarkable assertions being true was so low, that the bar for evidence was set rather high.
The evidence stacks up in rather complicated fashion. If your blister pack of ivermectin is half-full, you might find the arguments in favor of ivermectin’s efficacy convincing. Biological plausibility for its antiviral potential was established in April, 2020, by an Australian team led by Dr Leon Cary, Dr Kylie Wagstaff, and Dr David Jans, who showed that, in a laboratory in vitro setting, ivermectin rapidly cleared SARS-CoV-2 RNA from cells. Doubts were raised that real world human dosing of ivermectin could ever reach those experimental concentrations, but a single modeling study concluded that it would at least be a possibility in lung tissue. In any case, the race to study ivermectin in humans was on. Given the dismal circumstances in the spring of 2020, many regions, especially South America, began both to embrace and to study the use of ivermectin against Covid-19 on the premise of this hope.
More:
https://www.battleswarmblog.com/?p=49112
